UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.72 +0.70 (+0.90%) GOLD FUTURES
2,390.40 +30.50 (+1.29%) DOW
39,827.97 +269.86 (+0.68%) Bitcoin GBP
51,519.21 +3,101.91 (+6.41%)
Chugai Pharmaceutical Co., Ltd. (4519.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
| Previous close | 4,798.00 |
| Open | 4,833.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 4,801.00 - 4,884.00 |
| 52-week range | 3,581.00 - 6,697.00 |
| Volume | |
| Avg. volume | 2,489,760 |
| Market cap | 7.936T |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 24.34 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 82.00 (1.71%) |
| Ex-dividend date | 27 Jun 2024 |
| 1y target est | N/A |
- Zacks
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
- Zacks
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's Why
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
© 2024 Yahoo. All rights reserved.